Tybourne Capital Management (Hk) LTD has filed its 13F form on July 31, 2025 for Q2 2025 where it was disclosed a total value porftolio of $34.5 Billion distributed in 6 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Forte Biosciences Inc (Fbrx Us) with a value of $10.2B, Taysha Gene Therapies, Inc. with a value of $9.46B, Bicycle Therapeutics PLC with a value of $6.91B, Alumis Inc (Alms Us) with a value of $4.2B, and Malibu Boats, Inc. with a value of $2.09B.

Examining the 13F form we can see an increase of $11B in the current position value, from $23.6B to 34.5B.

Tybourne Capital Management (Hk) LTD is based out at Hong Kong, K3

Below you can find more details about Tybourne Capital Management (Hk) LTD portfolio as well as his latest detailed transactions.

Portfolio value $34.5 Billion
Healthcare: $18.1 Billion
Consumer Cyclical: $2.09 Billion

Stock Holdings Table Market Cap. of $300 Millions to $2 Billions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 6
  • Current Value $34.5 Billion
  • Prior Value $23.6 Billion
  • Filing
  • Period Q2 2025
  • Filing Date July 31, 2025
  • Form Type 13F-HR
  • Activity in Q2 2025
  • New Purchases 2 stocks
  • Additional Purchases 4 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 0 stocks
Track This Portfolio

Track Tybourne Capital Management (Hk) LTD Portfolio

Follow Tybourne Capital Management (Hk) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tybourne Capital Management (Hk) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Tybourne Capital Management (Hk) LTD with notifications on news.